BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31729307)

  • 1. FAT10: Function and Relationship with Cancer.
    Xiang S; Shao X; Cao J; Yang B; He Q; Ying M
    Curr Mol Pharmacol; 2020; 13(3):182-191. PubMed ID: 31729307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
    Bialas J; Groettrup M; Aichem A
    PLoS One; 2015; 10(3):e0120329. PubMed ID: 25768649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAT10ylation as a signal for proteasomal degradation.
    Schmidtke G; Aichem A; Groettrup M
    Biochim Biophys Acta; 2014 Jan; 1843(1):97-102. PubMed ID: 23333871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-like protein FAT10: A potential cardioprotective factor and novel therapeutic target in cancer.
    Zhang K; Chen L; Zhang Z; Cao J; He L; Li L
    Clin Chim Acta; 2020 Nov; 510():802-811. PubMed ID: 32946796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin-like modifier FAT10 in cancer development.
    Aichem A; Groettrup M
    Int J Biochem Cell Biol; 2016 Oct; 79():451-461. PubMed ID: 27393295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.
    Bialas J; Boehm AN; Catone N; Aichem A; Groettrup M
    J Biol Chem; 2019 Mar; 294(12):4315-4330. PubMed ID: 30718280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1.
    Aichem A; Catone N; Groettrup M
    FEBS J; 2014 Apr; 281(7):1848-59. PubMed ID: 24528925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation.
    Aichem A; Kalveram B; Spinnenhirn V; Kluge K; Catone N; Johansen T; Groettrup M
    J Cell Sci; 2012 Oct; 125(Pt 19):4576-85. PubMed ID: 22797925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers.
    Lee CG; Ren J; Cheong IS; Ban KH; Ooi LL; Yong Tan S; Kan A; Nuchprayoon I; Jin R; Lee KH; Choti M; Lee LA
    Oncogene; 2003 May; 22(17):2592-603. PubMed ID: 12730673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of modification and proteolytic targeting by the ubiquitin-like modifier FAT10.
    Aichem A; Boehm AN; Catone N; Schmidtke G; Groettrup M
    Methods Enzymol; 2019; 618():229-256. PubMed ID: 30850054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
    Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
    Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.
    Aichem A; Anders S; Catone N; Rößler P; Stotz S; Berg A; Schwab R; Scheuermann S; Bialas J; Schütz-Stoffregen MC; Schmidtke G; Peter C; Groettrup M; Wiesner S
    Nat Commun; 2018 Aug; 9(1):3321. PubMed ID: 30127417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ubiquitin-like modifier FAT10 covalently modifies HUWE1 and strengthens the interaction of AMBRA1 and HUWE1.
    Mueller S; Bialas J; Ryu S; Catone N; Aichem A
    PLoS One; 2023; 18(8):e0290002. PubMed ID: 37578983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newly translated proteins are substrates for ubiquitin, ISG15, and FAT10.
    Spinnenhirn V; Bitzer A; Aichem A; Groettrup M
    FEBS Lett; 2017 Jan; 591(1):186-195. PubMed ID: 27926780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Thermodynamic Properties of Fat10ylated Proteins Are Regulated by the Fat10ylation Site.
    Ravichandran A; Das R
    ACS Omega; 2024 May; 9(20):22265-22276. PubMed ID: 38799324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-like modifier FAT10 - much more than a proteasome-targeting signal.
    Aichem A; Groettrup M
    J Cell Sci; 2020 Jul; 133(14):. PubMed ID: 32719056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells.
    Gao Y; Theng SS; Zhuo J; Teo WB; Ren J; Lee CG
    Carcinogenesis; 2014 Apr; 35(4):923-34. PubMed ID: 24325913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-like protein FAT10 promotes osteosarcoma growth by modifying the ubiquitination and degradation of YAP1.
    Yi X; Deng X; Zhao Y; Deng B; Deng J; Fan H; Du Y; Hao L
    Exp Cell Res; 2020 Feb; 387(2):111804. PubMed ID: 31877302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NUB1 and FAT10 Proteins as Potential Novel Biomarkers in Cancer: A Translational Perspective.
    Arshad M; Abdul Hamid N; Chan MC; Ismail F; Tan GC; Pezzella F; Tan KL
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Leukocyte Antigen F Locus Adjacent Transcript 10 Overexpression Disturbs WISP1 Protein and mRNA Expression to Promote Hepatocellular Carcinoma Progression.
    Yan J; Lei J; Chen L; Deng H; Dong D; Jin T; Liu X; Yuan R; Qiu Y; Ge J; Peng X; Shao J
    Hepatology; 2018 Dec; 68(6):2268-2284. PubMed ID: 29790184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.